Javascript must be enabled to continue!
Carrier Detection in Classical Hemophilia
View through CrossRef
Rabbit antibody to purified human factor VIII was prepared and absorbed until it formed only one precipitin line against normal and hemophilic plasmas and no line against severe von Willebrand's disease plasma. The plasma protein which combines with this rabbit antibody to factor VIII is referred to as factor VIII antigen. The ratio of percent factor VIII activity (by coagulation assay) to percent factor VIII antigen was used for carrier detection. Thirty-seven normal women, 33 obligate carriers, 12 probable carriers, and 39 possible carriers, were studied by this technique. Using the ratio of 0.84 as the division between normals and carriers, 31 of the 33 carriers (91%) were classified as carriers. Twenty of the 39 possible carriers were classified as carriers (51%) and ten of the 12 probable carriers were positively identified. The results of discriminate analysis of all three variables (VIII activity, VIII antigen, and the ratio of VIII activity to VIII antigen indicated that the discrimination power of the ratio alone could not be improved by introducing the other variables on this set of data. These findings confirm the usefulness of the VIII activity to VIII antigen ratio in the detection of carriers of classical hemophilia.
American Academy of Pediatrics (AAP)
Title: Carrier Detection in Classical Hemophilia
Description:
Rabbit antibody to purified human factor VIII was prepared and absorbed until it formed only one precipitin line against normal and hemophilic plasmas and no line against severe von Willebrand's disease plasma.
The plasma protein which combines with this rabbit antibody to factor VIII is referred to as factor VIII antigen.
The ratio of percent factor VIII activity (by coagulation assay) to percent factor VIII antigen was used for carrier detection.
Thirty-seven normal women, 33 obligate carriers, 12 probable carriers, and 39 possible carriers, were studied by this technique.
Using the ratio of 0.
84 as the division between normals and carriers, 31 of the 33 carriers (91%) were classified as carriers.
Twenty of the 39 possible carriers were classified as carriers (51%) and ten of the 12 probable carriers were positively identified.
The results of discriminate analysis of all three variables (VIII activity, VIII antigen, and the ratio of VIII activity to VIII antigen indicated that the discrimination power of the ratio alone could not be improved by introducing the other variables on this set of data.
These findings confirm the usefulness of the VIII activity to VIII antigen ratio in the detection of carriers of classical hemophilia.
Related Results
An Antibody to Tissue Factor Pathway Inhibitor (PF-06741086) in Combination with Recombinant Factor VIIa Increases Hemostasis in Hemophilia Plasma without Excessive Thrombin Generation
An Antibody to Tissue Factor Pathway Inhibitor (PF-06741086) in Combination with Recombinant Factor VIIa Increases Hemostasis in Hemophilia Plasma without Excessive Thrombin Generation
Abstract
Hemophilia is a hereditary bleeding disorder caused by intrinsic coagulation pathway deficiencies of Factor VIII (hemophilia A) or Factor IX (hemophilia B)....
A low-cost Clinical Prediction model for identifying female hemophilia carriers and women and girls with hemophilia (WGH) in central China
A low-cost Clinical Prediction model for identifying female hemophilia carriers and women and girls with hemophilia (WGH) in central China
Abstract
Background While hemophilia is traditionally considered an X-linked recessive disorder mainly affecting males, ...
Hemophilia
Hemophilia
Hemophilia is a family of rare bleeding disorders characterized by deficiency of clotting factors. Hemophilia A is an inherited deficiency of factor VIII, whereas hemophilia B (Chris...
HAEMOcare: The First International Epidemiological Study Measuring Burden of Hemophilia in Developing Countries
HAEMOcare: The First International Epidemiological Study Measuring Burden of Hemophilia in Developing Countries
Introduction Optimizing hemophilia care remains challenging in developing countries. Burden-of-disease studies are important to develop strategies for improving hemophilia care.
...
The Molecular Genetics of Hemophilia A Stylianos
The Molecular Genetics of Hemophilia A Stylianos
Hemophilia A is a common X linked hereditary disorder of blood coagulation due to deficiency of factor 8. The gene for factor 8 has been cloned and characterized (Nature 312:326-34...
The relationship between joint health, kinesiophobia, physical activity level, and functional capacity in hemophilia patients: a case-control study
The relationship between joint health, kinesiophobia, physical activity level, and functional capacity in hemophilia patients: a case-control study
Objective: The objective of this research was twofold: to compare the physical activity levels and functional capacity of patients with hemophilia A to healthy individuals and to d...
The Prevalence of Cardiovascular Risk Factors in Individuals with Hemophilia
The Prevalence of Cardiovascular Risk Factors in Individuals with Hemophilia
Abstract
Abstract 4319
Background:
Increasing life expectancy in individuals with hemophilia has lead to a higher...
Antithrombotic Therapy in People with Hemophilia—A Narrative Review
Antithrombotic Therapy in People with Hemophilia—A Narrative Review
As the life expectancy of individuals with hemophilia continues to increase, the complexity of balancing bleeding risks and thrombotic management has become increasingly critical i...

